<DOC>
	<DOCNO>NCT00337623</DOCNO>
	<brief_summary>Corticosteroid therapy usually regard risk factor development posterior subcapsular cataract prospective study topic accurate assessment potential adverse effect lack . We evaluate change lens transparency administration systemic corticosteroid therapy least one year Scheimpflug photography quantification lens autofluorescence .</brief_summary>
	<brief_title>Impact Systemic Corticosteroid Therapy Lens Transparency Quantification Lens Autofluorescence .</brief_title>
	<detailed_description>Corticosteroid therapy usually regard risk factor development posterior subcapsular cataract prospective study topic accurate assessment potential adverse effect lack . We evaluate change lens transparency administration systemic corticosteroid therapy least one year Scheimpflug photography quantification lens autofluorescence .</detailed_description>
	<mesh_term>Prednisolone</mesh_term>
	<criteria>Patient start treatment Prednisone , Prednisolone Methylprednisolone Expected time one year least , normal lens autofluorescence inclusion . Previous cataract abnormal increase lens autofluorescence consider age Previous elevation intraocular pressure Progressive inflammatory non inflammatory ocular disease Eye drop except artificial tear Insulin dependent non insulin dependent diabetes Atopic dermatitis Previous protract corticosteroid therapy Drugs know associate increase risk cataract</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Cataracts</keyword>
	<keyword>Corticosteroids</keyword>
	<keyword>Scheimpflug</keyword>
	<keyword>Lens autofluorescence</keyword>
</DOC>